The prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.

Basit Öğe Kaydı
dc.authoridAlgın, Efnan/0000-0002-8917-9267
dc.authoridAraz, Murat/0000-0002-4632-9501
dc.authoridbenekli, mustafa/0000-0003-3184-4946
dc.authoridaksoy, asude/0000-0002-5609-9658
dc.authorwosidAlgın, Efnan/AHD-2377-2022
dc.authorwosidulger, Sukran/HHS-1463-2022
dc.authorwosidÖzet, ahmet/ABC-9831-2021
dc.authorwosidAraz, Murat/C-6388-2015
dc.authorwosidunal, olcun umit/IST-6684-2023
dc.authorwosidbenekli, mustafa/AAE-4555-2020
dc.authorwosidTufan, Gulnihal/HIZ-9729-2022
dc.contributor.authorTuran, Nedim
dc.contributor.authorAraz, Murat
dc.contributor.authorAlgin, Efnan
dc.contributor.authorUnal, Olcun Umit
dc.contributor.authorBenekli, Mustafa
dc.contributor.authorTastekin, Didem
dc.contributor.authorDane, Faysal
dc.date.accessioned2024-06-12T11:22:26Z
dc.date.available2024-06-12T11:22:26Z
dc.date.issued2015
dc.departmentTrakya Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer -- MAY 29-JUN 02, 2015 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2015.33.15_suppl.e15238
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2015.33.15_suppl.e15238
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25928
dc.identifier.volume33en_US
dc.identifier.wosWOS:000358036903002en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleThe prognostic value of lymph node ratio in patients with curatively resected pancreatic adenocarcinoma.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu